ISSN 2306-5559 (print)
ISSN 2410-938X (online)
ISSN 2410-938X (online)
нет
1. Kirkali Z, Van Poppel H. A critical analysis of surgery for kidney cancer with vena cava invasion. Eur Urol. 2007 Sep;52(3):658-62. doi: 10.1016/j.eururo.2007.05.009. Epub 2007 May 24. PMID: 17548146.2. https://www.cancer.gov/types/kidney/hp/kidney-treatment-pdq3. Patard, J.J., et al. Correlation between symptom graduation, tumor characteristics and survival in renal cell carcinoma. Eur Urol, 2003. 44: 2264. Lee, C.T., et al. Mode of presentation of renal cell carcinoma provides prognostic information. Urol Oncol, 2002. 7: 135.5. Vasudev, N.S., et al. Challenges of early renal cancer detection: symptom patterns and incidental diagnosis rate in a multicentre prospective UK cohort of patients presenting with suspected renal cancer. BMJ Open, 2020. 10: e035938.6. Haidar GM, Hicks TD, El-Sayed HF, Davies MG. Treatment options and outcomes for cavalthrombectomy and resection for renal cell carcinoma. J Vasc Surg Venous LymphatDisord May. 2017;5(3):430–6.7. Gonzalez J. Update on surgical management of renal cell carcinoma with venous extension. CurrUrol Rep Feb. 2012;13(1):8–15.8. Calero A, Armstrong PA. Renal cell carcinoma accompanied by venous invasion and inferior vena cava thrombus: classification and operative strategies for the vascular surgeon. SeminVasc Surg Dec. 2013;26(4):219–25.9. Marshall FF, Reitz BA, Diamond DA. A new technique for management of renal cell carcinoma involving the right atrium: hypothermia and cardiac arrest. J Urol. 1984;131(1):103–7.10. Belis JA, Levinson ME, Pae WE Jr. Complete radical nephrectomy and vena cavalthrombectomy during circulatory arrest. J Urol. 2000;163(2):434–6.11. Blute ML, Leibovich BC, Lohse CM, Cheville JC, Zincke H. The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. BJU Int. 2004 Jul;94(1):33-41. doi: 10.1111/j.1464-410X.2004.04897.x. PMID: 15217427.12. Zisman A, Wieder JA, Pantuck AJ, et al. Renal cell carcinoma with tumor thrombus extension: biology, role of nephrectomy and response to immunotherapy. J Urol 2003;169:909-16. 10.1097/01.ju.0000045706.35470.1e13. Lam JS, Klatte T, Breda A. Staging of renal cell carcinoma: Current concepts. Indian J Urol 2009;25:446-54. 10.4103/0970-1591.5790614. Dall'Oglio MF, Ribeiro-Filho LA, Antunes AA, et al. Microvascular tumor invasion, tumor size and Fuhrman grade: a pathological triad for prognostic evaluation of renal cell carcinoma. J Urol 2007;178:425-8; discussion 428. 10.1016/j.juro.2007.03.12815. Ghoreifi, A., Djaladat, H. Surgical Tips for Inferior Vena Cava Thrombectomy. Curr Urol Rep 21, 51 (2020). https://doi.org/10.1007/s11934-020-01007-916. Xie, W., Regan, M. M., Buyse, M., et al. (2008). Metastasis-free survival is a strong surrogate of overall survival in localized renal cell carcinoma. Journal of Clinical Oncology, 26(22), 3749-3755.17. Abel, E. J., Thompson, R. H., Margulis, V., et al. (2014). Perioperative outcomes following surgical resection of renal cell carcinoma with inferior vena cava thrombus extending above the hepatic veins: A contemporary multicenter experience. European Urology, 66(3), 584-592.18. Zhu P, Du S, Chen S, Zheng S, Hu Y, Liu L, Zheng S. The role of deep hypothermic circulatory arrest in surgery for renal or adrenal tumor with vena cava thrombus: a single-institution experience. J Cardiothorac Surg. 2018 Jul 5;13(1):85. doi: 10.1186/s13019-018-0772-z. PMID: 29976214; PMCID: PMC6034231.19. Ferda, J., et al. Assessment of the kidney tumor vascular supply by two-phase MDCT-angiography. Eur J Radiol, 2007. 62: 295.20. Shao, P., et al. Precise segmental renal artery clamping under the guidance of dual-source computed tomography angiography during laparoscopic partial nephrectomy. Eur Urol, 2012. 62: 1001.21. Abel, E. J., Thompson, R. H., Margulis, V., et al. (2014). Perioperative outcomes following surgical resection of renal cell carcinoma with inferior vena cava thrombus extending above the hepatic veins: A contemporary multicenter experience. European Urology, 66(3), 584-592. 22. Haferkamp, A., Hafez, K., Schmidt, S., et al. (2007). Renal cell carcinoma with tumor thrombus extension into the vena cava: prospective long-term followup. The Journal of Urology, 177(5), 1703-1708. 23. Blute, M. L., Leibovich, B. C., Lohse, C. M., et al. (2004). The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumor thrombus. The Journal of Urology, 171(5), 1803-1807. 24. Bex, A., Albiges, L., Ljungberg, B., et al. (2018). Updated European Association of Urology guidelines for renal cell carcinoma: Immune checkpoint inhibition is the new backbone in first-line treatment of metastatic clear-cell renal cell carcinoma. European Urology, 74(4), 455-463. 25. Staehler, M., Koch, A. F., Haseke, N., et al. (2011). Perioperative risk of patients with renal cell carcinoma and inferior vena cava thrombus extension treated without cardiopulmonary bypass. European Urology, 59(4), 589-597. 26. Delahunt, B., Eble, J. N. (1997). History of the development of the classification of renal cell neoplasia. Clinical Laboratory Medicine, 17(4), 605-622. 27. Shuch, B., Hofmann, F., Gill, I. S., et al. (2011). The expanding role of partial nephrectomy: a critical analysis of indications, outcomes, and complications. European Urology, 59(5), 744-752.